• Explore /
  • Poster
  • / Safety and preliminary activity of hydroxychloroquine and aldesleukin in metastatic renal cell carcinoma (mRCC): A cytokine working group study.

Safety and preliminary activity of hydroxychloroquine and aldesleukin in metastatic renal cell carcinoma (mRCC): A cytokine working group study.

Abstract Poster

Authors

Leonard Appleman

Leonard Joseph Appleman

University of Pittsburgh, Pittsburgh, PA

Leonard Joseph Appleman , Theodore F. Logan , Daniel Paul Normolle , Marc S. Ernstoff , Rahul Atul Parikh , David F. McDermott , Paul Monk III, Thomas Olencki , David Friedland , Jodi Kathleen Maranchie , Michael T. Lotze

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Penile, Urethral, and Testicular Cancers; Renal Cell Cancer

Track

Renal Cell Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Renal Cell Cancer

Clinical Trial Registration Number

NCT01550367

Citation

J Clin Oncol 35, 2017 (suppl 6S; abstract 440)

DOI

10.1200/JCO.2017.35.6_suppl.440

Abstract #

440

Poster Bd #

D3

Abstract Disclosures

Similar Posters

First Author: Leonard Joseph Appleman

First Author: Leonard Joseph Appleman

First Author: Christopher B. Allard

First Author: Rongsu Qi